Quest Diagnostics Inc (DGX)
167.55 x 1 184.37 x 1
Post-market by (Cboe BZX)
172.24 +0.10 (+0.06%) 02/21/25 [NYSE]
167.55 x 1 184.37 x 1
Post-market 172.24 unch (unch) 16:08 ET
for Fri, Feb 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Sales | 9,872,000 | 9,252,000 | 9,883,000 | 10,788,000 | 9,437,000 |
Cost of Goods | 6,628,000 | 6,199,000 | 6,450,000 | 6,579,000 | 5,804,000 |
Gross Profit | 3,244,000 | 3,053,000 | 3,433,000 | 4,209,000 | 3,633,000 |
Operating Expenses | 1,898,000 | 1,791,000 | 2,005,000 | 1,828,000 | 1,662,000 |
Operating Income | 1,346,000 | 1,262,000 | 1,428,000 | 2,381,000 | 1,971,000 |
Interest Expense | 201,000 | 152,000 | 138,000 | 151,000 | 163,000 |
Other Income | 49,000 | 46,000 | -11,000 | 447,000 | 151,000 |
Pre-tax Income | 1,194,000 | 1,156,000 | 1,279,000 | 2,677,000 | 1,959,000 |
Income Tax | 273,000 | 248,000 | 264,000 | 597,000 | 460,000 |
Net Income Continuous | 921,000 | 908,000 | 1,015,000 | 2,080,000 | 1,499,000 |
Minority Interests | 50,000 | 54,000 | 69,000 | 85,000 | 68,000 |
Net Income | $871,000 | $854,000 | $946,000 | $1,995,000 | $1,431,000 |
EPS Basic Total Ops | 7.78 | 7.59 | 8.10 | 15.85 | 10.62 |
EPS Basic Continuous Ops | 8.30 | 8.11 | 8.75 | 16.64 | 11.19 |
EPS Diluted Total Ops | 7.69 | 7.49 | 7.97 | 15.55 | 10.47 |
EPS Diluted Continuous Ops | 8.15 | 8.04 | 8.60 | 16.25 | 11.02 |
EPS Diluted Before Non-Recurring Items | 8.93 | 8.71 | 9.95 | 14.24 | 11.18 |
EBITDA(a) | $1,839,000 | $1,701,000 | $1,865,000 | $2,789,000 | $2,332,000 |